Fortress Biotech
FBIO
#9379
Rank
S$0.11 B
Marketcap
S$3.67
Share price
2.91%
Change (1 day)
33.00%
Change (1 year)

Earnings for Fortress Biotech (FBIO)

Earnings in 2025 (TTM): -S$0.12 Billion

According to Fortress Biotech 's latest financial reports the company's current earnings are S$59.3 Million. In 2024 the company made an earning of -S$0.16 Billion, an increase over its 2023 earnings that were of -S$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fortress Biotech from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.12 Billion-24.72%
2024 -S$0.16 Billion-21.6%
2023 -S$0.2 Billion-28.03%
2022 -S$0.28 Billion29.88%
2021 -S$0.22 Billion59.8%
2020 -S$0.14 Billion1.17%
2019 -S$0.14 Billion-19.84%
2018 -S$0.17 Billion28.99%
2017 -S$0.13 Billion37.92%
2016 -S$92.39 Million32.31%
2015 -S$69.83 Million164.31%
2014 -S$26.42 Million-45.14%
2013 -S$48.16 Million37.55%
2012 -S$35.01 Million-22.91%
2011 -S$45.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Advaxis
ADXS
-S$44.1 Million-61.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
S$32.06 M-127.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.16 Billion 32.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
-S$43.92 Million-61.90%๐Ÿ‡บ๐Ÿ‡ธ USA